KURA ONCOLOGY INC (KURA)
US50127T1097 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.32M | 51.80M | 90.70M | 325.50M | 26.10M | |||
| Marketable Securities | 386.64M | 386.20M | 427.30M | 307.80M | 210.80M | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 8.52M | 8.40M | 4.30M | 4.00M | 2.70M | |||
| Total Current Assets | 432.48M | 446.40M | 522.30M | 637.30M | 239.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.85M | 6.40M | 8.20M | 8.40M | 300.00K | |||
| Other Non-Current Assets | 7.60M | 3.50M | 3.50M | 1.60M | 2.10M | |||
| Total Non-Current Assets | 16.45M | 9.90M | 11.80M | 9.90M | 2.40M | |||
| TOTAL ASSETS | 448.94M | 456.30M | 534.10M | 647.20M | 242.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 3.00M | 300.00K | |||
| Accrued Expenses | 32.96M | 22.50M | 19.20M | 20.30M | 11.80M | |||
| Accounts Payable | 2.30M | 1.50M | 3.20M | 2.80M | 3.50M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 35.26M | 24.10M | 22.50M | 26.00M | 15.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 9.33M | 9.20M | 0.00 | 4.30M | 7.30M | |||
| Other Non-Current Liabilities | 7.07M | 2.80M | 5.00M | 6.00M | 400.00K | |||
| Total Non-Current Liabilities | 16.40M | 11.90M | 4.90M | 10.30M | 7.60M | |||
| TOTAL LIABILITIES | 51.66M | 36.00M | 27.40M | 36.30M | 23.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -721.44M | -568.80M | -433.00M | -302.50M | -212.90M | |||
| Additional Paid In Capital | 1.12B | 997.10M | 941.40M | 913.40M | 431.30M | |||
| Common Shares | 7.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.27M | -8.00M | -1.80M | 0.00 | 300.00K | |||
| Shares Outstanding | 74.35M | 68.30M | 66.60M | 66.20M | 45.40M | |||
| Tangible Book Value per Share | 5.34 | 6.15 | 7.61 | 9.23 | 4.82 | |||
| Total Shareholders' Equity | 397.27M | 420.30M | 506.60M | 610.90M | 218.80M | |||
| TOTAL LIABILITIES AND EQUITY | 448.94M | 456.30M | 534.10M | 647.20M | 242.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | N/A | 0.01 | 0.03 | |||
| Current Ratio | 12.26 | 18.52 | 23.21 | 24.51 | 15.36 | |||
| Return On Assets (ROA) | -34.00% | -29.77% | -24.43% | -13.85% | -26.09% | |||
| Return On Equity (ROE) | -38.42% | -32.32% | -25.75% | -14.67% | -28.86% | |||
All data in USD